Newborn jaundice (neonatal hyperbilirubinemia) is a common condition, affecting up to 60–80% of infants in the first week of life (Kemper et al., 2022). It manifests as a yellowing of the skin/eyes due to elevated bilirubin. For lactation professionals, understanding the types of newborn jaundice, their risk factors, and how to support breastfeeding in each scenario is crucial. Most jaundiced newborns can safely continue breastfeeding, with supplementation or other interventions considered case by case (CDC, 2025). Breastfeeding offers benefits that generally outweigh the mild risks of jaundice, so maintaining lactation is a priority in management.
Physiologic Jaundice (Early Normal Jaundice)
Physiologic jaundice is the most common type. It usually appears after the first 24 hours of life, peaks around days 3–4, and resolves by about 2 weeks in full-term infants (Kemper et al., 2022). It results from normal newborn biology: babies have a high red blood cell turnover and an immature liver, plus delayed meconium passage can increase bilirubin reabsorption (CDC, 2025). Consequently, most newborns have bilirubin levels above adult norms, which is considered harmless in physiologic jaundice (CDC, 2025).
Risk Factors
Prematurity (gestation <38 weeks) is a key risk factor – preterm infants often have higher and longer-lasting bilirubin elevations (Kemper et al., 2022). Other factors that can raise bilirubin include birth injuries (bruising or cephalohematomas) and maternal conditions like diabetes (which can cause polycythemia in the infant) (Kemper et al., 2022). These conditions increase bilirubin production or reduce clearance, but without an underlying disease, this is still “physiologic” in many cases.
Breastfeeding Support
There is no need to stop breastfeeding during mild physiologic jaundice (Flaherman et al., 2017). In fact, frequent breastfeeding helps resolve jaundice. Aim for 8–12 feedings per day to promote hydration and frequent stooling, which aids bilirubin excretion (CDC. 2025). Lactation consultants should encourage early initiation of breastfeeding (within the first hour of life) and on-demand feeds thereafter (Flaherman et al., 2017). This early, frequent feeding improves milk intake and hydration, thereby reducing bilirubin levels (CDC, 2025). Monitor the infant’s output and weight: adequate wet/dirty diapers and <10% weight loss indicate sufficient intake. If the baby is feeding well and gaining weight, physiologic jaundice will typically self-resolve with no interruption to breastfeeding.
Pathologic Jaundice (Hemolytic or Early-Onset)
Pathologic jaundice refers to jaundice caused by an underlying condition, often occurring within the first 24 hours of life or leading to very high bilirubin levels. It can result from excessive bilirubin production (e.g. due to hemolysis) or impaired bilirubin processing. This type is less common but more serious, as extremely high bilirubin can cause neurotoxicity if untreated (Kemper et al., 2022). Any jaundice visible on day 1 should be promptly evaluated by a pediatric provider (Kemper et al., 2022).
Risk Factors
Blood group incompatibilities – e.g. ABO or Rh incompatibility causing hemolytic disease of the newborn Lawrence & Lawrence, 2022). (Infants born to an Rh-negative or type O mother are at risk for antibody-mediated hemolysis.)
Genetic hemolytic conditions – e.g. Glucose-6-phosphate dehydrogenase (G6PD) deficiency or hereditary spherocytosis, which predispose to high bilirubin (Lawrence & Lawrence, 2022). G6PD deficiency is more common in certain ethnic groups and can cause rapid jaundice in a breastfed newborn.
Prematurity or illness – preterm infants (who have less albumin binding and immature livers) and babies with neonatal infections (sepsis) or birth asphyxia are at higher risk (Kemper et al., 2022).
Extensive bruising/hematomas – such as cephalohematoma from birth trauma, which increases red cell breakdown (Lawrence & Lawrence, 2022).
Breastfeeding Support
Babies with pathologic jaundice will often require medical treatments like phototherapy or even exchange transfusion in severe cases. Breastfeeding should still be supported during treatment whenever possible. The American Academy of Pediatrics (AAP) advises that phototherapy may be briefly paused (up to ~30 minutes) to allow breastfeeding, as maintaining lactation is important (Kemper et al., 2022). Lactation consultants can help mothers breastfeed or provide expressed milk during phototherapy sessions, and encourage skin-to-skin contact if feasible. If an infant is too ill or lethargic to nurse effectively (for example, intensive care or during an exchange transfusion), mothers should be supported to express milk and maintain supply until direct breastfeeding can resume (CDC, 2025). Reassure parents that their milk did not cause the hemolytic jaundice – the underlying condition is to blame – and emphasize that breast milk is the optimal nutrition for recovery. In some cases of hemolysis, supplementing with additional expressed breast milk or formula may be recommended to ensure adequate hydration and calorie intake (especially if >10% weight loss or poor output), but this should be decided on an individual basis (Kemper et al., 2022). Throughout, positive encouragement from health professionals is key, since mothers of jaundiced infants are at higher risk of early breastfeeding cessation without support (Kemper et al., 2022).
“Breastfeeding” Jaundice (Suboptimal Intake Jaundice)
So-called breastfeeding jaundice is better termed suboptimal intake jaundice, because it is not caused by breast milk itself, but by inadequate milk intake in the first few days of lifeabm.memberclicks.net. It typically occurs in the first week as breastfeeding is being established (CDC, 2025). When a newborn isn’t receiving enough milk (e.g. due to infrequent feeds or latch difficulties), they may become slightly dehydrated and have delayed meconium passage, leading to higher bilirubin levels (since bilirubin in the intestines gets reabsorbed instead of excreted) (CDC, 2025). This type of jaundice is essentially an exaggeration of physiologic jaundice due to low caloric/fluid intake.
Risk Factors
Suboptimal intake jaundice is more likely in scenarios of insufficient breastfeeding. Risk factors include a poor latch or ineffective sucking, very infrequent nursing (less than 8 times in 24 hours), mother’s milk coming in late (delayed lactogenesis), or a particularly sleepy or ineffective feeder (which can sometimes be both a cause and effect of rising bilirubin). Primiparous mothers and those with difficult deliveries might experience more breastfeeding challenges in the first days, putting babies at risk for this jaundice. Excessive weight loss (>10% of birth weight by day 5) and scanty wet/stool diapers are warning signs of suboptimal intake that often coincide with this jaundice (Kemper et al., 2022).
Breastfeeding Support
The cornerstone of managing breastfeeding jaundice is to increase the infant’s milk intake. Lactation consultants should assess and improve the breastfeeding technique: ensure proper latch and positioning, and help mothers wake a sleepy newborn to feed at least 8–12 times per day (Lawrence & Lawrence, 2022). Early follow-up is crucial; monitor weight and hydration status closely. If the infant’s intake remains low or bilirubin continues rising despite optimized feeding, judicious supplementation may be needed to augment intake and prevent more severe jaundice (Kemper et al, 2022). According to the Academy of Breastfeeding Medicine (ABM) and CDC, any supplementation should preferably be with expressed breast milk or donor human milk; formula is used if human milk isn’t available – and this decision is made on a case-by-case basis (CDC, 2025). Supplementation can be temporary and done via cup, spoon, or syringe feeding to avoid nipple confusion, if possible. Importantly, the mother should continue to breastfeed or pump frequently even while supplementing, to stimulate milk production. With improved intake, bilirubin levels will drop as the baby hydrates and stools more frequently (CDC, 2025).
Education and reassurance are key! Explain that this jaundice is due to feeding difficulties, not a problem with the breast milk itself. By resolving the feeding issues – with skilled lactation support – the jaundice will likewise resolve, and exclusive breastfeeding can continue successfully.
Breast Milk Jaundice (Late-Onset Prolonged Jaundice)
Breast milk jaundice is a prolonged, benign jaundice seen in some healthy breastfed infants. It typically becomes noticeable after the first week (around days 7–10) and can persist for several weeks, even up to 3–6 weeks of age (CDC, 2025). These babies are often thriving with good weight gain; the jaundice is believed to be caused by substances in certain mothers’ milk that slightly inhibit bilirubin metabolism in the infant’s liver (CDC, 2025). The exact mechanism isn’t fully understood, but it results in elevated unconjugated bilirubin that is otherwise asymptomatic. Breast milk jaundice must be distinguished from other causes of prolonged jaundice (for instance, cholestatic liver diseases present with direct bilirubin and other signs). Notably, breast milk jaundice is not harmful in itself – bilirubin levels here are usually moderate and eventually decline.
Risk Factors
There are no specific preventable risk factors for breast milk jaundice; it appears to be an idiopathic phenomenon in an exclusively breastfed infant. A history of the condition in older siblings can increase suspicion, suggesting a familial pattern. It occurs in a small percentage of nursing infants and by definition requires that other pathological causes are ruled out. If a breastfed baby remains noticeably jaundiced beyond 2–3 weeks of age, current guidelines recommend checking the direct bilirubin level to ensure there is no cholestasis or other illness masked by the “breast milk jaundice” label (Kemper et al., 2022).
Breastfeeding Support
Continue breastfeeding! Breast milk jaundice does not require stopping breastfeeding in most cases (Lawrence & Lawrence, 2022). The AAP and ABM note that these infants can safely continue to nurse, as long as they are otherwise well (good intake and growth) (Kemper et al, 2022). . Abrupt weaning is not indicated – doing so would deprive the infant of the benefits of breast milk without clear evidence of benefit. Instead, reassure parents that this form of jaundice is usually transient and benign. The care team should monitor bilirubin trends and the baby’s weight. If bilirubin levels are high, pediatricians might use phototherapy for a short period while the baby stays with the mother; during phototherapy breaks, direct breastfeeding is encouraged. In rare instances (extreme bilirubin levels or diagnostic uncertainty), a temporary 24–48 hour interruption of breastfeeding might be advised to see if bilirubin levels drop rapidly (which suggests breast milk jaundice)(CDC, 2025). If this brief weaning trial is done, it is critical to support the mother in maintaining her milk supply with regular pumping (CDC, 2025). After the trial, breastfeeding should be resumed immediately. Throughout, the lactation consultant’s role is to reinforce that the mother’s milk is still the best nutrition. Emphasize the plan: no long-term cessation is needed, and the jaundice will resolve on its own. Encouraging words and evidence-based information can alleviate a family’s worry and prevent unnecessary early weaning.
Conclusion
For each type of newborn jaundice, the overarching principle is that breastfeeding can and should continue in most cases, with appropriate support and medical management alongside. Frequent feeding is both preventive and therapeutic for jaundice (CDC, 2025). Lactation professionals should work closely with pediatric providers to ensure jaundiced infants get timely treatments (like phototherapy or supplements when indicated) without undermining breastfeeding. By educating parents on the nature of the jaundice and actively supporting mother–infant feeding, we help families navigate neonatal jaundice while preserving the many benefits of breastfeeding. With proper guidance and reassurance, even jaundice can be an opportunity to strengthen, rather than derail, a successful breastfeeding journey (Kemper et al., 2022).
References
Centers for Disease Control and Prevention. (2025, February 14). Jaundice and breastfeeding: Breastfeeding special circumstances. U.S. Department of Health and Human Services.
Flaherman, V.J., Maisels, J., and the Academy of Breastfeeding Medicine. (2017). ABM clinical protocol #22: Guidelines for management of jaundice in the breastfeeding infant ≥35 weeks’ gestation. Breastfeeding Medicine, 12(5), 250–257. https://www.bfmed.org/assets/DOCUMENTS/PROTOCOLS/22-jaundice-protocol-english.pdfhttps://www.cdc.gov/breastfeeding-special-circumstances/hcp/illnesses-conditions/jaundice.html
Kemper, A. R., Newman, T. B., Slaughter, J. L., Maisels, M. J., Watchko, J. F., Downs, S. M., Grout, R. W., Bundy, D. G., Stark, A. R., Bogen, D. L., Volpe Holmes, A., Feldman-Winter, L. B., Bhutani, V. K., Brown, S. R., Maradiaga Panayotti, G. M., Okechukwu, K., Rappo, P. D., & Russell, T. L. (2022). Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics, 150(3), Article e2022058859. https://doi.org/10.1542/peds.2022-058859
Lawrence, R. A., & Lawrence, R. M. (2022). Breastfeeding: A guide for the medical profession (8th ed.). Elsevier.
Wambach, K., & Riordan, J. (2015). Breastfeeding and human lactation (5th ed.). Jones & Bartlett Learning.
